ANGELA VELEZ: Open Payments
NPI 1558558809 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 45 payments from 12 companies in 2025. Trend: 2023 $969 · 2024 $1,650 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $199 |
| Almatica Pharma LLC | 5 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Alkermes, Inc. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $24 |
Products named: VRAYLAR, REXULTI, LOREEV XR, CAPLYTA, LYBALVI, Jornay PM, FANAPT, SPRAVATO.
Industry payments across TX — which companies pay providers there.
